Literature DB >> 20002500

Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France.

E K Déti1, R Thiébaut, F Bonnet, S Lawson-Ayayi, M Dupon, D Neau, J L Pellegrin, D Malvy, S Tchamgoué, F Dabis, P Morlat.   

Abstract

OBJECTIVES: The aims of the present study were to estimate the prevalence of renal impairment (RI) among HIV-infected adult patients and to investigate the associated factors.
METHODS: A cross-sectional survey was conducted in a French hospital-based cohort. Clearance of creatinine (CC) was calculated using the Cockcroft-Gault formula. Four stages of RI were defined: mild (60-90 mL/min), moderate (30-60), severe (15-30) and end stage (<15). Logistic regression models were used to investigate factors associated with RI.
RESULTS: The male/female ratio of the 2588 patients enrolled was 3:1 and the median age was 42 years. At the time of assessment of CC, the median CD4 count was 430 cells/microL and HIV plasma viral load (VL) was<50 copies/mL in 60%. The overall prevalence of RI was 39.0%: 34.2% mild, 4.4% moderate, 0.3% severe and 0.2% end-stage. Mild RI was associated with female gender [odds ratio (OR)=3.3: 95% CI 2.6-4.3)], age >50 years (OR=9.8: 7.4-13.0) and 40-50 years (OR=1.9: 1.5-2.4), body mass index (BMI) <22 kg/m(2) (OR=3.3: 2.7-4.3) and tenofovir exposure (OR=1.4: 1.0-1.9 for <1 year and OR=1.5: 1.2-2.0 for >1 year). Advanced RI (CC <60 mL/min) was associated with age >50 years (OR=5.6: 2.9-10.9) and 40-50 years (OR=2.2: 1.1-1.4), BMI <22 kg/m(2) (OR=1.5: 1.0-2.4), hypertension (OR=2.5: 1.4-2.5) and indinavir (IDV) exposure >1 year (OR=2.3: 1.5-3.6).
CONCLUSION: This survey confirms the high prevalence of RI in HIV-infected patients and indicates the importance of the investigation of renal function especially in women, older patients, those with a low BMI or treated with tenofovir or IDV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20002500     DOI: 10.1111/j.1468-1293.2009.00780.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  25 in total

Review 1.  Renal disease in HIV-infected individuals.

Authors:  John Phair; Frank Palella
Journal:  Curr Opin HIV AIDS       Date:  2011-07       Impact factor: 4.283

Review 2.  HIV therapies and the kidney: some good, some not so good?

Authors:  Lene Ryom; Amanda Mocroft; Jens Lundgren
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

Review 3.  Renal dysfunction in the setting of HIV/AIDS.

Authors:  Jose M Miro; Federico Cofan; Joan C Trullas; Christian Manzardo; Carlos Cervera; Montserrat Tuset; Federico Oppenheimer; Mercedes Brunet; Asuncion Moreno; Josep M Campistol; Jose M Gatell
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

4.  Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4(+) T-cell count.

Authors:  Beatriz Grinsztejn; Laura Smeaton; Ronald Barnett; Karin Klingman; James Hakim; Timothy Flanigan; N Kumarasamy; Thomas Campbell; Judith Currier
Journal:  Antivir Ther       Date:  2011

5.  Contributory role of ART in the development of non-AIDS comorbidities in asymptomatic PLWHA.

Authors:  Karen Ingrid Tasca; Vania V M Fagundes Vidal; Vanessa Martinez Manfio; Alexandre Naime Barbosa; Lenice do Rosario de Souza
Journal:  J Appl Biomed       Date:  2021-01-27       Impact factor: 1.797

6.  Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.

Authors:  Lene Ryom; Amanda Mocroft; Ole Kirk; Signe W Worm; David A Kamara; Peter Reiss; Michael Ross; Christoph A Fux; Philippe Morlat; Olivier Moranne; Colette Smith; Jens D Lundgren
Journal:  J Infect Dis       Date:  2013-02-04       Impact factor: 5.226

7.  Prevalence of renal disease within an urban HIV-infected cohort in northern Italy.

Authors:  Leonardo Calza; Elisa Vanino; Eleonora Magistrelli; Caterina Salvadori; Alessandra Cascavilla; Vincenzo Colangeli; Maria Assunta Di Bari; Roberto Manfredi; Pierluigi Viale
Journal:  Clin Exp Nephrol       Date:  2013-05-28       Impact factor: 2.801

8.  Prevalence of proteinuria and elevated serum cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) study.

Authors:  Kristal J Aaron; Mirjam-Colette Kempf; Robert H Christenson; Craig M Wilson; Paul Muntner; Sadeep Shrestha
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

Review 9.  Kidney disease in children and adolescents with perinatal HIV-1 infection.

Authors:  Rajendra Bhimma; Murli Udharam Purswani; Udai Kala
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

10.  Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012.

Authors:  Philippe Morlat; Alexandre Vivot; Marie-Anne Vandenhende; Frédéric-Antoine Dauchy; Julien Asselineau; Edouard Déti; Yann Gerard; Estibaliz Lazaro; Pierre Duffau; Didier Neau; Fabrice Bonnet; Geneviève Chêne
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.